Vendor, Durham, NC
Health Decisions, Inc.
UEI CMKQYLSLNJG1, CAGE 3FAM0
16 awards and $11,806,748 obligated between February 1, 2024 and October 22, 2026, 69% under full and open competition, against 2.0 offers on average where reported. 5 of the awards trace back to a SAM.gov solicitation on this site.
Industries
NAICS on the awards, by dollars.
| Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)NAICS 541715 | $11,400,323 |
| Professional, Scientific, and Technical ServicesNAICS 541712 | $406,426 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition After Exclusion of Sources | 11 |
| Full and Open Competition | 5 |
| Small Business Set Aside - Total | 1 |
| Delivery Order | 15 |
Hear when Health Decisions, Inc. wins an award and when a contract it holds is about to end.Follow it
Contracts ending soon
Contracts Health Decisions, Inc. holds whose performance ends in the next 19 months, by published end date. Each one is a recompete to prepare for.
- Ending
- 4
- Obligated so far
- $3,437,240
- Soonest
- July 31, 2027
The 4 contracts, the office behind each one and the dates are in the workspace. See them
Competes with
Vendors selling research and development in the physical, engineering, and life sciences (except nanotechnology and biotechnology) to National Institutes of Health, by dollars.
| Leidos Biomedical Research Inc.Frederick, MD | $2,186,369,442 |
| Westat, Inc.Rockville, MD | $760,724,225 |
| Technical Resources International, Inc.Bethesda, MD | $196,391,189 |
| Duke UniversityDurham, NC | $158,758,507 |
| MriglobalKansas City, MO | $117,921,746 |
| The Johns Hopkins UniversityBaltimore, MD | $100,932,043 |
Solicitations it won
SAM.gov opportunities whose award USAspending attributes to this vendor.
- NICHD Contraceptive Clinical Trials Network Statistical and Clinical Coordinating Center
National Institutes of Health, National Institutes of Health Nichd
JustificationNAICS 541715Morrisville, NC75N94019D00004Awarded to Health Decisions, Inc.
Posted Jan 8, 20255 publications
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75N94023F00002Delivery Order, February 1, 2024, Full and Open Competition After Exclusion of Sources | National Institutes of Health NichdNational Institutes of Health | Statistical and Clinical Coordinating Services for Groups C and D of CCN021 Entitled, "a Study to Evaluate the PK and PD of Im or SQ InjectiNAICS 541715, PSC AN12 | $1,783,803 |
| 75N94023F00001Delivery Order, September 13, 2024, Full and Open Competition After Exclusion of Sources | National Institutes of Health NichdNational Institutes of Health | Coordination, Monitoring, Follow-Up, and Evaluation of a Clinical Trial of Nestorone Testosterone Gel for Male ContraceptionNAICS 541715, PSC AN12 | $1,484,684 |
| 75N94025F00002Delivery Order, July 25, 2025, Full and Open Competition After Exclusion of Sources | National Institutes of Health NichdNational Institutes of Health | Nichd: R&d: Supporting the Phase Iib Clinical Trial of Subcutaneous Levonorgestrel Butanoate (Lb) for Female Contraception: Non-SeverableNAICS 541715, PSC AN12 | $1,286,724 |
| 75N94025F00001Delivery Order, April 30, 2025, Full and Open Competition After Exclusion of Sources | National Institutes of Health NichdNational Institutes of Health | Nichd: R&d: Coordination, Monitoring, Follow-Up, Evaluation, and Completion of a Clinical Trial of Nestorone Testosterone Gel for Male ContrNAICS 541715, PSC AN12 | $1,230,826 |
| 75N94024F00002Delivery Order, September 24, 2024, Full and Open Competition After Exclusion of Sources | National Institutes of Health NichdNational Institutes of Health | Acquisition of the Nestorone Estradiol (Nes/E2) Vaginal RingNAICS 541715, PSC AN12 | $1,199,999 |
| 75N94019F00126Delivery Order, March 28, 2024, Full and Open Competition After Exclusion of Sources | National Institutes of Health NichdNational Institutes of Health | Task Order 2: Status Determination and Prioritization of Pipeline Products Undergoing Clinical Trials for Male and Female ContraceptionNAICS 541715, PSC AN12 | $1,147,456 |
| 75N94019F00125Delivery Order, August 20, 2024, Full and Open Competition After Exclusion of Sources | National Institutes of Health NichdNational Institutes of Health | Statistical, Clinical Coordinating Support and Services to the Contraceptive Clinical Trials Network and Nichd for a Variety of Tasks RelateNAICS 541715, PSC AN12 | $1,060,416 |
| 75N94024F00001Delivery Order, September 19, 2024, Full and Open Competition After Exclusion of Sources | National Institutes of Health NichdNational Institutes of Health | Protocol Finalization, Start-Up, Coordination, Monitoring, and All Other Associated Activities for Clinical Trials Evaluating Progestogenic NAICS 541715, PSC AN12 | $994,099 |
| 75N94023F00003Delivery Order, July 18, 2024, Full and Open Competition After Exclusion of Sources | National Institutes of Health NichdNational Institutes of Health | Finalization, Procurement of Regulatory Approval, and Complete Start-Up Activities for the Ovaprene Vaginal Device Clinical TrialNAICS 541715, PSC AN12 | $717,192 |
| 75N94026F00001Delivery Order, September 18, 2026, Full and Open Competition After Exclusion of Sources | National Institutes of Health NichdNational Institutes of Health | Nichd:r&d:cctn Statistical and Clinical Coordinating Center (Sccc) Core Function Activities:severableNAICS 541715, PSC AN12 | $495,123 |
| HHSN27500005Delivery Order, August 14, 2024, Full and Open Competition | National Institutes of Health NichdNational Institutes of Health | Evaluation of the Pharmacokinetic Profile, Effects on the Mechanisms of Contraceptive Efficacy and Safety of Multipurpose Prevention TechnolNAICS 541712, PSC AN12 | $432,060 |
| HHSN27500006Delivery Order, April 26, 2024, Full and Open Competition | National Institutes of Health NichdNational Institutes of Health | Contraceptive Clinical Trials Network TO6 - Coordination of Clinical Trials of Novel Products for Female ContraceptionNAICS 541712, PSC AN12 | $0 |
| HHSN27500007Delivery Order, February 12, 2024, Full and Open Competition | National Institutes of Health NichdNational Institutes of Health | Coordination of Clinical Trials of Progestogenic Androgens for Male ContraceptionNAICS 541712, PSC AN12 | $0 |
| 75N94019D00004December 17, 2024, Full and Open Competition After Exclusion of Sources, 2 offersSolicitation | National Institutes of Health NichdNational Institutes of Health | The Statistical and Clinical Coordinating Center IDIQNAICS 541715, PSC AN12 | $0 |
| 75N94018F00009Delivery Order, October 22, 2024, Full and Open Competition | National Institutes of Health NichdNational Institutes of Health | Hhsn275201200002i/Hhsn27500009 - Contraceptive Clinical Trials Network, Clinical Evaluation of LARC Methods to Determine Comparative EffectiNAICS 541712, PSC AN12 | -$1 |
| HHSN27500001Delivery Order, April 22, 2024, Full and Open Competition | National Institutes of Health NichdNational Institutes of Health | Contraceptive Clinical Trials Network - Core Function ActivitiesNAICS 541712, PSC AN12 | -$25,634 |
- Places of performance
- North Carolina
- Product and service codes
- AN12 Health R&D Services; Health Care Services; Applied Research
- Transactions
- 59 across 16 awards